KCS Wealth Advisory’s Elevance Health ELV Stock Holding History

KCS Wealth Advisory’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.93M	Buy	6,727 +248	+4%	+$112K	1.25%	21
2023 Q2	$2.88M	Buy	6,479 +497	+8%	+$229K	1%	30
2023 Q1	$2.75M	Buy	5,982 +652	+12%	+$310K	1.04%	30
2022 Q4	$2.73M	Buy	5,330 +137	+3%	+$69.6K	1.14%	25
2022 Q3	$2.36M	Buy	5,193 +513	+11%	+$245K	1.09%	27
2022 Q2	$2.26M	Buy	4,680 +112	+2%	+$55.4K	1%	31
2022 Q1	$2.24M	Buy	4,568 +164	+4%	+$75K	1.04%	31
2021 Q4	$2.04M	Buy	4,404 +1,247	+39%	+$525K	0.82%	36
2021 Q3	$1.18M	Buy	3,157 +98	+3%	+$37.2K	0.56%	62
2021 Q2	$1.17M	Buy	3,059 +63	+2%	+$24.1K	0.55%	64
2021 Q1	$1.07M	Buy	2,996 +247	+9%	+$79.4K	0.56%	66
2020 Q4	$883K	Buy	2,749 +111	+4%	+$34.1K	0.58%	67
2020 Q3	$709K	Buy	2,638 +89	+3%	+$23.9K	0.57%	71
2020 Q2	$670K	Buy	2,549 +61	+2%	+$16.3K	0.55%	71
2020 Q1	$565K	Buy	2,488 +293	+13%	+$79.8K	0.57%	70
2019 Q4	$663K	Buy	2,195 +59	+3%	+$16.2K	0.5%	87
2019 Q3	$513K	Buy	2,136 +119	+6%	+$32.6K	0.35%	102
2019 Q2	$569K	Buy	2,017 +377	+23%	+$103K	0.45%	92
2019 Q1	$471K	Buy	1,640 +295	+22%	+$85.3K	0.41%	100
2018 Q4	$353K	Buy	1,345 +108	+9%	+$29.7K	0.37%	109
2018 Q3	$339K	Buy	1,237 +133	+12%	+$34.5K	0.31%	115
2018 Q2	$263K	Buy	1,104 +55	+5%	+$12.7K	0.25%	133
2018 Q1	$230K	Buy	+1,049	New	+$246K	0.21%	145

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCS Wealth Advisory's ELV Position: Q3 2023 in Review

KCS Wealth Advisory increased its Elevance Health (ELV) stake by 3.8% in Q3 2023, buying an estimated $112K and bringing the position to 6,727 shares worth $2.93M. The position accounts for 1.25% of the portfolio, ranked #21.

KCS Wealth Advisory first reported a position in ELV in Q1 2018 and has held it in 23 quarters since. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

KCS Wealth Advisory held 6,727 shares of Elevance Health worth $2.93M as of Q3 2023.
KCS Wealth Advisory bought 248 Elevance Health shares in Q3 2023, an estimated $112K.
Elevance Health made up 1.25% of KCS Wealth Advisory's portfolio in Q3 2023, its #21 holding.
KCS Wealth Advisory first reported a position in Elevance Health in Q1 2018 and has held it in 23 quarters since.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on KCS Wealth Advisory's 13F filing for Q3 2023, filed 3 Nov 2023.